190
Participants
Start Date
April 1, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Oxaliplatin by arterial infusion plus S-1
3 cycles oxaliplatin by arterial infusion plus S-1 every 21 days as neoadjuvant chemotherapy.
SOX neoadjuvant
3 cycles of SOX neoadjuvant chemotherapy every 21 days.
Sintilimab neoadjuvant
3 cycles of neoadjuvant immunotherapy every 21 days.
gastrectomy plus D2 lymph node dissection
All patients, whose lesions are resectable and medically operable after 3 cycles neoadjuvant chemotherapy, will receive gastrectomy plus D2 lymph node dissection.
SOX adjuvant, Sequential S-1
"3 cycles of SOX adjuvant chemotherapy every 21 days after surgery in both groups.~Sequential S-1 chemotherapy every 21 days till 1 year postoperation."
Sintilimab adjuvant
3 cycles of adjuvant immunotherapy every 21 days.
RECRUITING
Gastrointestinal Department of Second Affiliated Hospital of Zhejiang University, Hangzhou
Zhejiang University
OTHER